| Literature DB >> 27670688 |
Kristin E Burnum-Johnson1, Song Nie1, Cameron P Casey1, Matthew E Monroe1, Daniel J Orton1, Yehia M Ibrahim1, Marina A Gritsenko1, Therese R W Clauss1, Anil K Shukla1, Ronald J Moore1, Samuel O Purvine1, Tujin Shi1, Weijun Qian1, Tao Liu1, Erin S Baker2, Richard D Smith2.
Abstract
Current proteomic approaches include both broad discovery measurements and quantitative targeted analyses. In many cases, discovery measurements are initially used to identify potentially important proteins (e.g. candidate biomarkers) and then targeted studies are employed to quantify a limited number of selected proteins. Both approaches, however, suffer from limitations. Discovery measurements aim to sample the whole proteome but have lower sensitivity, accuracy, and quantitation precision than targeted approaches, whereas targeted measurements are significantly more sensitive but only sample a limited portion of the proteome. Herein, we describe a new approach that performs both discovery and targeted monitoring (DTM) in a single analysis by combining liquid chromatography, ion mobility spectrometry and mass spectrometry (LC-IMS-MS). In DTM, heavy labeled target peptides are spiked into tryptic digests and both the labeled and unlabeled peptides are detected using LC-IMS-MS instrumentation. Compared with the broad LC-MS discovery measurements, DTM yields greater peptide/protein coverage and detects lower abundance species. DTM also achieved detection limits similar to selected reaction monitoring (SRM) indicating its potential for combined high quality discovery and targeted analyses, which is a significant step toward the convergence of discovery and targeted approaches.Mesh:
Substances:
Year: 2016 PMID: 27670688 PMCID: PMC5141281 DOI: 10.1074/mcp.M116.061143
Source DB: PubMed Journal: Mol Cell Proteomics ISSN: 1535-9476 Impact factor: 5.911